BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10731436)

  • 1. Decreased left ventricular ejection fraction in transgenic mice expressing mutant cardiac troponin T-Q(92), responsible for human hypertrophic cardiomyopathy.
    Lim DS; Oberst L; McCluggage M; Youker K; Lacy J; DeMayo F; Entman ML; Roberts R; Michael LH; Marian AJ
    J Mol Cell Cardiol; 2000 Mar; 32(3):365-74. PubMed ID: 10731436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice.
    Oberst L; Zhao G; Park JT; Brugada R; Michael LH; Entman ML; Roberts R; Marian AJ
    J Clin Invest; 1998 Oct; 102(8):1498-505. PubMed ID: 9788962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transgenic rabbit model for human hypertrophic cardiomyopathy.
    Marian AJ; Wu Y; Lim DS; McCluggage M; Youker K; Yu QT; Brugada R; DeMayo F; Quinones M; Roberts R
    J Clin Invest; 1999 Dec; 104(12):1683-92. PubMed ID: 10606622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo short-term expression of a hypertrophic cardiomyopathy mutation in adult rabbit myocardium: myofibrillar incorporation without early disarray.
    Yu Q; Zhao G; Marian AJ
    Proc Assoc Am Physicians; 1999; 111(1):45-56. PubMed ID: 9893156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.
    Lombardi R; Bell A; Senthil V; Sidhu J; Noseda M; Roberts R; Marian AJ
    Cardiovasc Res; 2008 Jul; 79(1):109-17. PubMed ID: 18349139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility.
    Marian AJ; Zhao G; Seta Y; Roberts R; Yu QT
    Circ Res; 1997 Jul; 81(1):76-85. PubMed ID: 9201030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy.
    Tardiff JC; Factor SM; Tompkins BD; Hewett TE; Palmer BM; Moore RL; Schwartz S; Robbins J; Leinwand LA
    J Clin Invest; 1998 Jun; 101(12):2800-11. PubMed ID: 9637714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
    Tsybouleva N; Zhang L; Chen S; Patel R; Lutucuta S; Nemoto S; DeFreitas G; Entman M; Carabello BA; Roberts R; Marian AJ
    Circulation; 2004 Mar; 109(10):1284-91. PubMed ID: 14993121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice.
    Lutucuta S; Tsybouleva N; Ishiyama M; Defreitas G; Wei L; Carabello B; Marian AJ
    J Am Coll Cardiol; 2004 Dec; 44(11):2221-30. PubMed ID: 15582321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy.
    Lim DS; Lutucuta S; Bachireddy P; Youker K; Evans A; Entman M; Roberts R; Marian AJ
    Circulation; 2001 Feb; 103(6):789-91. PubMed ID: 11171784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.
    Nagueh SF; Chen S; Patel R; Tsybouleva N; Lutucuta S; Kopelen HA; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
    J Mol Cell Cardiol; 2004 May; 36(5):663-73. PubMed ID: 15135661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias.
    Frey N; Franz WM; Gloeckner K; Degenhardt M; Müller M; Müller O; Merz H; Katus HA
    Cardiovasc Res; 2000 Aug; 47(2):254-64. PubMed ID: 10946062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.
    Tardiff JC; Hewett TE; Palmer BM; Olsson C; Factor SM; Moore RL; Robbins J; Leinwand LA
    J Clin Invest; 1999 Aug; 104(4):469-81. PubMed ID: 10449439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy.
    Lucas DT; Aryal P; Szweda LI; Koch WJ; Leinwand LA
    Am J Physiol Heart Circ Physiol; 2003 Feb; 284(2):H575-83. PubMed ID: 12414446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular genetic basis for hypertrophic cardiomyopathy.
    Marian AJ; Roberts R
    J Mol Cell Cardiol; 2001 Apr; 33(4):655-70. PubMed ID: 11273720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCM-linked ∆160E cardiac troponin T mutation causes unique progressive structural and molecular ventricular remodeling in transgenic mice.
    Moore RK; Grinspan LT; Jimenez J; Guinto PJ; Ertz-Berger B; Tardiff JC
    J Mol Cell Cardiol; 2013 May; 58():188-98. PubMed ID: 23434821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy.
    Ahmad F; Banerjee SK; Lage ML; Huang XN; Smith SH; Saba S; Rager J; Conner DA; Janczewski AM; Tobita K; Tinney JP; Moskowitz IP; Perez-Atayde AR; Keller BB; Mathier MA; Shroff SG; Seidman CE; Seidman JG
    PLoS One; 2008 Jul; 3(7):e2642. PubMed ID: 18612386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Jenab Y; Pourjafari M; Darabi F; Boroumand MA; Zoroufian A; Jalali A
    J Cardiol; 2014 Feb; 63(2):140-4. PubMed ID: 24011925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy.
    Nagueh SF; Kopelen HA; Lim DS; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
    Circulation; 2000 Sep; 102(12):1346-50. PubMed ID: 10993850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changes of the cardiac structure and function in cTnTR141W transgenic mice.
    Juan F; Wei D; Xiongzhi Q; Ran D; Chunmei M; Lan H; Chuan Q; Lianfeng Z
    Int J Cardiol; 2008 Aug; 128(1):83-90. PubMed ID: 18606313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.